527 related articles for article (PubMed ID: 10930856)
1. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A
Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
[TBL] [Abstract][Full Text] [Related]
2. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
Gomez EC; Kaminester L; Frost P
Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
[TBL] [Abstract][Full Text] [Related]
3. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.
Lucky AW; Grote GD; Williams JL; Tuley MR; Czernielewski JM; Dolak TM; Herndon JH; Baker MD
Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
5. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
Meyer E; Smith EW; Haigh JM; Kanfer I
Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
[TBL] [Abstract][Full Text] [Related]
6. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
7. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
Abramovits W; Oquendo M
Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
[TBL] [Abstract][Full Text] [Related]
8. Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis.
Eichenfield LF; Basu S; Calvarese B; Trancik RJ
Pediatr Dermatol; 2007; 24(3):289-95. PubMed ID: 17542883
[TBL] [Abstract][Full Text] [Related]
9. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis.
Schlessinger J; Miller B; Gilbert RD; Plott RT;
Arch Dermatol; 2006 Dec; 142(12):1568-72. PubMed ID: 17178982
[TBL] [Abstract][Full Text] [Related]
10. Desonide foam 0.05%: safety in children as young as 3 months.
Hebert AA;
J Am Acad Dermatol; 2008 Aug; 59(2):334-40. PubMed ID: 18638631
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream.
Chunharas A; Wisuthsarewong W; Wananukul S; Viravan S
J Med Assoc Thai; 2002 Apr; 85(4):482-7. PubMed ID: 12118496
[TBL] [Abstract][Full Text] [Related]
12. [Clinical test with Apolar cream and Calmuril-hydrocortisone cream in contact dermatitis and atopic dermatitis].
Gip L
Tidsskr Nor Laegeforen; 1978 Apr; 98(10):509-10. PubMed ID: 354085
[No Abstract] [Full Text] [Related]
13. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood.
Queille C; Pommarede R; Saurat JH
Pediatr Dermatol; 1984 Jan; 1(3):246-53. PubMed ID: 6494068
[TBL] [Abstract][Full Text] [Related]
14. Sicorten: a synthetic corticosteroid for topical treatment of common dermatoses.
Majerus JP; Reiffers-Mettelock J
J Int Med Res; 1986; 14(1):46-9. PubMed ID: 2937673
[TBL] [Abstract][Full Text] [Related]
15. [Comparative clinical trial of a new trihalogenated dermatocorticoid (halometasone) versus betamethasone dipropionate].
Schuppli R; Dressler H; Yawalkar SJ; Weirich EG
Z Hautkr; 1983 Feb; 58(4):230-7. PubMed ID: 6342285
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with topical corticosteroids in severe or resistant dermatoses].
Nolting S
Derm Beruf Umwelt; 1985; 33(4):140-4. PubMed ID: 2931266
[TBL] [Abstract][Full Text] [Related]
17. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
Elewski B
Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
[TBL] [Abstract][Full Text] [Related]
18. An overview of international clinical trials with halometasone cream.
Yawalkar SJ; Macarol V; Montanari C
J Int Med Res; 1983; 11 Suppl 1():1-7. PubMed ID: 6339286
[TBL] [Abstract][Full Text] [Related]
19. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
Peserico A; Städtler G; Sebastian M; Fernandez RS; Vick K; Bieber T
Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
[TBL] [Abstract][Full Text] [Related]
20. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
